Julie Cothren, DPh
Implementation of new standards for handling hazardous drugs (HDs) in healthcare facilities is coming closer to reality now that the calendar has flipped to 2019. United States Pharmacopeial Convention (USP) General Chapter <800> focuses on protecting healthcare workers through the safe handling of HDs in healthcare settings (Figure
There is no longer a compliance exemption for low-volume hazardous sterile compounding, as is currently allowed in USP <797>; however, oncology clinics may be held to less stringent standards if all admixtures are prepared for use within 12 hours. If a clinic receives, handles, stores, compounds, dispenses, administers, or disposes of HDs, it will be affected by USP <800> standards, and this will be far-reaching and costly for many practices.
Figure. Essential Groundwork For USP <800> Implementation
... to read the full story